10-K: Lowell Farms Inc. Reports Full Year 2023 Results, Navigates Market Challenges

Lowell Farms Inc. reports a net loss for 2023, impacted by market pressures and strategic shifts, including exiting its cultivation facility.

Summary

• Lowell Farms Inc., a California-based cannabis company, reported its full-year 2023 results, showing a net loss of $37.3 million compared to a $24.6 million loss in 2022.
• The company's revenue decreased by 35% to $28.3 million in 2023 from $43.5 million in 2022, with declines across all revenue categories including CPG, bulk, Lowell Farm Services, and licensing.
• Gross margin was negative at -26.3% in 2023, compared to -4.2% in 2022, due to inventory impairments, lease reclassifications, and yield variances.
• Operating expenses decreased to $10.1 million in 2023 from $15.3 million in 2022, primarily due to lower salaries, professional fees, and marketing expenses.
• The company repurchased $22.1 million of convertible debentures, issuing 6.8 million subordinate voting shares and membership interests in LF Brandco LLC.
• Lowell Farms surrendered its 255,000 square foot cultivation facility in January 2024, incurring significant impairment charges.
• The company is shifting its focus to sourcing flower from third-party growers and expanding its processing and distribution services.

Sentiment

Score: 3

Explanation: The document presents a challenging financial picture with significant losses, declining revenue, and negative gross margins. While there are some positive steps taken, the overall tone is negative due to the company's financial struggles and strategic shifts.

Positives

• Operating expenses decreased by $5.2 million year-over-year, indicating cost-cutting measures.
• The company improved its working capital position by $16.6 million year-over-year.
• The company has secured a $1 million credit on royalty expenses with Brandco.
• The company is focusing on improving accounts receivable collections and right-sizing inventories.
• The company is focusing on smaller, more frequent production runs to lower inventory working capital and expedite product to market.

Negatives

• The company experienced a significant net loss of $37.3 million in 2023.
• Revenue decreased by 35% year-over-year, indicating a decline in sales.
• Gross margin was negative at -26.3%, reflecting high production costs and inventory write-downs.
• The company incurred significant impairment charges related to the cultivation facility and intangible assets.
• The company surrendered its cultivation facility, which may impact future supply chain control.

Risks

• The company has limited access to capital, which may hinder its ability to fund operations and growth.
• The company is dependent on California bulk market prices, which are volatile and can impact profitability.
• Cannabis remains illegal under U.S. federal law, posing a risk to the company's operations.
• The company may face difficulties enforcing contracts in federal and some state courts.
• The company is subject to risks inherent in agricultural operations, even with third-party sourcing.
• The company is subject to potential legal proceedings related to the Zabala Road lease and product labeling.

Future Outlook

The company plans to focus on the California market, expand its proprietary and licensed brands, leverage its manufacturing and distribution capabilities, and source competitively priced cannabis flower and biomass. The company will selectively seek opportunities to expand its brands and operations in California through acquisitions or alliances.

Management Comments

• Management believes that focusing on the substantial California market and becoming profitable and self-sustaining is the appropriate near-term growth strategy for the Company.
• Management plans to capitalize on cannabis consumption in California through the expansion of proprietary and licensed brands, robust manufacturing and processing capabilities, and leveraging its expansive distribution footprint.
• Management believes that its processing capabilities will enable sourcing competitively priced, high-quality cannabis flower and biomass.

Industry Context

The U.S. cannabis market is expected to grow, but California's legal cannabis sales decreased for the second year in a row in 2023. The company faces intense competition from both legal and illicit markets, and is navigating challenges such as high taxes and a limited number of dispensaries.

Comparison to Industry Standards

• The company's negative gross margin of -26.3% is significantly below industry standards, indicating operational inefficiencies and high production costs compared to peers.
• The company's revenue decline of 35% contrasts with the expected growth in the U.S. cannabis market, suggesting challenges in market share and brand competitiveness.
• The company's decision to exit its cultivation facility is a strategic shift, which may be similar to other cannabis companies that are focusing on cost-cutting and efficiency.
• The company's focus on third-party distribution and processing services aligns with the trend of specialization in the cannabis industry, similar to companies like KushCo Holdings (now Greenlane Holdings) that focus on ancillary services.
• The company's challenges in maintaining profitability and managing debt are common among smaller cannabis companies, while larger players like Curaleaf and Trulieve have shown better financial performance.

Management Changes

Legal Proceedings

• The company is involved in a lawsuit with its former landlord regarding the Zabala Road lease, with the landlord claiming damages of more than $36 million.
• The company is also facing a putative class action lawsuit related to product potency and labeling.

Related Party Transactions

• Certain officers and directors purchased convertible debentures during the third quarter of 2022 that converted in October 2023.
• The company has a licensing agreement with Brandco, an entity formed to hold the company's intellectual property, in which insiders of the company hold membership interests.
• The company has a lease agreement with Cannaco Research Corporation, a company where a director is the CEO.

Stakeholder Impact

• Shareholders face significant risk due to the company's financial losses and strategic shifts.
• Employees may be impacted by cost-cutting measures and the exit from the cultivation facility.
• Customers may experience changes in product availability and pricing due to the company's strategic shifts.
• Suppliers may be affected by the company's shift to third-party sourcing.
• Creditors may be concerned about the company's ability to meet its financial obligations.

Next Steps

• The company will focus on sourcing flower from third-party growers.
• The company will expand its processing and distribution services.
• The company will selectively seek opportunities to expand its brands and operations in California through acquisitions or alliances.

Key Dates

Keywords

cannabis, California, cultivation, manufacturing, distribution, financial results, impairment, revenue, gross margin, operating expenses, convertible debentures, intellectual property, legal proceedings